Metraipolis › archive › dc_902fa06a993e

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42233029
DOI
10.3389/fimmu.2026.1806527
License (as archived)
solo-consultazione
Archived
2026-11-02T05:17:31.451Z
SHA-256 of the archived text
5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca
Stable URL of this page
https://metraipolis.com/documento/dc_902fa06a993e

How to cite

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029 — Europe PMC (en), https://europepmc.org/article/MED/42233029 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_902fa06a993e (Metraipolis archive dc_902fa06a993e, sha256 5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca)
BibTeX
@misc{dc902fa06a993e,
  title = {Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease — Europe PMC PMID:42233029},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42233029},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_902fa06a993e; sha256 5ff84bc18593c74bba7b1f0b8f7349be9089422e4e66663869fee00a21f66eca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42233029. Agents can read the archived copy with the MCP tool read_document.